Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 16, 16:01
1553.00 -7.80 (-0.50%)
Volume
AVERAGE VOLUME
5-Day
168,525
10-Day
90,223
30-Day
81,901
8,218
  • Prev. Close

    1560.80

  • Open Price

    1579.65

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Mar 16, 16:03
1557.00 -4.30 (-0.28%)
Volume
AVERAGE VOLUME
5-Day
241,625
10-Day
170,969
30-Day
197,936
181,093
  • Prev. Close

    1561.30

  • Open Price

    1565.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Balance Sheet of Ipca Laboratories (in Rs. Cr.) Mar 05 Mar 04  
  12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 25.00 12.50  
Total Share Capital 25.00 12.50  
Reserves and Surplus 312.59 263.17  
Total Reserves and Surplus 312.59 263.17  
Total Shareholders Funds 337.59 275.67  
NON-CURRENT LIABILITIES  
Long Term Borrowings 10.52 47.62  
Deferred Tax Liabilities [Net] 43.73 29.28  
Other Long Term Liabilities 0.00 0.00  
Long Term Provisions 0.00 0.00  
Total Non-Current Liabilities 54.25 76.90  
CURRENT LIABILITIES  
Short Term Borrowings 209.85 107.02  
Trade Payables 59.07 57.78  
Other Current Liabilities 26.32 21.05  
Short Term Provisions 11.46 21.48  
Total Current Liabilities 306.71 207.32  
Total Capital And Liabilities 698.55 559.90  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 291.46 180.38  
Intangible Assets 2.84 1.70  
Capital Work-In-Progress 28.17 13.83  
Other Assets 0.00 0.00  
Fixed Assets 322.46 195.92  
Non-Current Investments 10.29 15.15  
Deferred Tax Assets [Net] 0.79 0.28  
Long Term Loans And Advances 0.00 0.00  
Other Non-Current Assets 0.00 0.00  
Total Non-Current Assets 333.54 211.34  
CURRENT ASSETS  
Current Investments 0.00 0.00  
Inventories 173.87 150.22  
Trade Receivables 157.16 139.04  
Cash And Cash Equivalents 4.17 4.75  
Short Term Loans And Advances 29.82 54.54  
OtherCurrentAssets 0.00 0.00  
Total Current Assets 365.01 348.55  
Total Assets 698.55 559.90  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 66.64 62.20  
CIF VALUE OF IMPORTS  
Raw Materials 73.76 78.40  
Stores, Spares And Loose Tools 0.00 0.00  
Trade/Other Goods 0.00 0.00  
Capital Goods 12.76 6.59  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 34.64 24.31  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods 390.97 340.16  
Other Earnings -- 2.23  
BONUS DETAILS  
Bonus Equity Share Capital 20.90 8.40  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- --  
Non-Current Investments Unquoted Book Value 10.29 20.40  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- --  
Current Investments Unquoted Book Value -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347